Arsenic-induced malignant transformation of human keratinocytes: Involvement of Nrf2

Free Radical Biology and Medicine

Volumn 45, Issue 5, 2008, Pages 651-658

  Pi, Jingbo ^a,b   Diwan, Bhalchandra A ^c   Sun, Yang ^a   Liu, Jie ^a   Qu, Wei ^a   He, Yuying ^a   Styblo, Miroslav ^d   Waalkes, Michael P ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b HAMNER INSTITUTES FOR HEALTH SCIENCES   (United States)

^c SAIC FREDERICK INC   (United States)

^d IL   (United States)

Author keywords

Arsenic; Carcinogenesis; CK2; Nrf2; Oxidative stress

Indexed keywords

ARSENIC; ARSENIC TRIOXIDE; BIOLOGICAL MARKER; CYTOKERATIN 1; CYTOKERATIN 10; GELATINASE B; GLUTATHIONE; INVOLUCRIN; LORICRIN; RNA; TRANSCRIPTION FACTOR NRF2;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; ENZYME RELEASE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; KERATINIZATION; KERATINOCYTE; LONG TERM EXPOSURE; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; NUDE MOUSE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN CANCER; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; ULTRAVIOLET B RADIATION; ULTRAVIOLET IRRADIATION; WESTERN BLOTTING; ZYMOGRAPHY;

APOPTOSIS; ARSENITES; CASEIN KINASE II; CELL LINE; CELL NUCLEUS; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; KERATINOCYTES; NF-E2-RELATED FACTOR 2;

MUS MUSCULUS;

EID: 48449084354     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2008.05.020     Document Type: Article

References (50)

1. IARC. Arsenic and arsenic compounds. IARC monograph on the evaluation of the carcinogenic risk to human-overall evaluations of carcinogenicity: an update of IARC monographs 1 to 42 (1987), IARC, Lyon, France
2. Waalkes M.P., Ward J.M., and Diwan B.A. Induction of tumors of the liver, lung, ovary and adrenal in adult mice after brief maternal gestational exposure to inorganic arsenic: promotional effects of postnatal phorbol ester exposure on hepatic and pulmonary, but not dermal cancers. Carcinogenesis 25 (2004) 133-141
3. Rossman T.G., Uddin A.N., Burns F.J., and Bosland M.C. Arsenite is a cocarcinogen with solar ultraviolet radiation for mouse skin: an animal model for arsenic carcinogenesis. Toxicol. Appl. Pharmacol. 176 (2001) 64-71
4. Germolec D.R., Spalding J., Yu H.S., Chen G.S., Simeonova P.P., Humble M.C., Bruccoleri A., Boorman G.A., Foley J.F., Yoshida T., and Luster M.I. Arsenic enhancement of skin neoplasia by chronic stimulation of growth factors. Am. J. Pathol. 153 (1998) 1775-1785
5. Pi J., Yamauchi H., Kumagai Y., Sun G., Yoshida T., Aikawa H., Hopenhayn-Rich C., and Shimojo N. Evidence for induction of oxidative stress caused by chronic exposure of Chinese residents to arsenic contained in drinking water. Environ. Health Perspect. 110 (2002) 331-336
6. Pi J., Qu W., Reece J.M., Kumagai Y., and Waalkes M.P. Transcription factor Nrf2 activation by inorganic arsenic in cultured keratinocytes: involvement of hydrogen peroxide. Exp. Cell Res. 290 (2003) 234-245
7. Kessel M., Liu S.X., Xu A., Santella R., and Hei T.K. Arsenic induces oxidative DNA damage in mammalian cells. Mol. Cell. Biochem. 234-235 (2002) 301-308
8. Shi H., Hudson L.G., Ding W., Wang S., Cooper K.L., Liu S., Chen Y., Shi X., and Liu K.J. Arsenite causes DNA damage in keratinocytes via generation of hydroxyl radicals. Chem. Res. Toxicol. 17 (2004) 871-878
9. Hei T.K., and Filipic M. Role of oxidative damage in the genotoxicity of arsenic. Free Radic. Biol. Med. 37 (2004) 574-581
10. Pi J., He Y., Bortner C., Huang J., Liu J., Zhou T., Qu W., North S.L., Kasprzak K.S., Diwan B.A., Chignell C.F., and Waalkes M.P. Low level, long-term inorganic arsenite exposure causes generalized resistance to apoptosis in cultured human keratinocytes: potential role in skin co-carcinogenesis. Int. J. Cancer 116 (2005) 20-26
11. Ding W., Hudson L.G., and Liu K.J. Inorganic arsenic compounds cause oxidative damage to DNA and protein by inducing ROS and RNS generation in human keratinocytes. Mol. Cell. Biochem. 279 (2005) 105-112
12. Wang T.C., Jan K.Y., Wang A.S., and Gurr J.R. Trivalent arsenicals induce lipid peroxidation, protein carbonylation, and oxidative DNA damage in human urothelial cells. Mutat. Res. 615 (2007) 75-86
13. Piao F., Ma N., Hiraku Y., Murata M., Oikawa S., Cheng F., Zhong L., Yamauchi T., Kawanishi S., and Yokoyama K. Oxidative DNA damage in relation to neurotoxicity in the brain of mice exposed to arsenic at environmentally relevant levels. J. Occup. Health 47 (2005) 445-449
14. Yamauchi H., Aminaka Y., Yoshida K., Sun G., Pi J., and Waalkes M.P. Evaluation of DNA damage in patients with arsenic poisoning: urinary 8-hydroxydeoxyguanine. Toxicol. Appl. Pharmacol. 198 (2004) 291-296
15. Kobayashi M., and Yamamoto M. Nrf2-Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species. Adv. Enzyme Regul. 46 (2006) 113-140
16. Ramos-Gomez M., Kwak M.K., Dolan P.M., Itoh K., Yamamoto M., Talalay P., and Kensler T.W. Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proc. Natl. Acad. Sci. USA 98 (2001) 3410-3415
17. Chan K., Han X.D., and Kan Y.W. An important function of Nrf2 in combating oxidative stress: detoxification of acetaminophen. Proc. Natl. Acad. Sci. USA 98 (2001) 4611-4616
18. Padmanabhan B., Tong K.I., Ohta T., Nakamura Y., Scharlock M., Ohtsuji M., Kang M.I., Kobayashi A., Yokoyama S., and Yamamoto M. Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer. Mol. Cell 21 (2006) 689-700
19. Singh A., Misra V., Thimmulappa R.K., Lee H., Ames S., Hoque M.O., Herman J.G., Baylin S.B., Sidransky D., Gabrielson E., Brock M.V., and Biswal S. Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer. PLoS Med. 3 (2006) e420
20. Stacy D.R., Ely K., Massion P.P., Yarbrough W.G., Hallahan D.E., Sekhar K.R., and Freeman M.L. Increased expression of nuclear factor E2 p45-related factor 2 (NRF2) in head and neck squamous cell carcinomas. Head Neck 28 (2006) 813-818
21. Boukamp P., Petrussevska R.T., Breitkreutz D., Hornung J., Markham A., and Fusenig N.E. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106 (1988) 761-771
22. Pi J., Kumagai Y., Sun G., Yamauchi H., Yoshida T., Iso H., Endo A., Yu L., Yuki K., Miyauchi T., and Shimojo N. Decreased serum concentrations of nitric oxide metabolites among Chinese in an endemic area of chronic arsenic poisoning in inner Mongolia. Free Radic. Biol. Med. 28 (2000) 1137-1142
23. Bershadsky A.D., Gelfand V.I., and Vasiliev J.M. Multinucleation of transformed cells normalizes their spreading on the substratum and their cytoskeleton structure. Cell Biol. Int. Rep. 5 (1981) 143-150
24. Pi J., Bai Y., Reece J.M., Williams J., Liu D., Freeman M.L., Fahl W.E., Shugar D., Liu J., Qu W., Collins S., and Waalkes M.P. Molecular mechanism of human Nrf2 activation and degradation: Role of sequential phosphorylation by protein kinase CK2. Free Radic. Biol. Med. 42 (2007) 1797-1806
25. Pinna L.A. Protein kinase CK2: a challenge to canons. J. Cell Sci. 115 (2002) 3873-3878
26. Shi H., Hudson L.G., and Liu K.J. Oxidative stress and apoptosis in metal ion-induced carcinogenesis. Free Radic. Biol. Med. 37 (2004) 582-593
27. Schafer F.Q., and Buettner G.R. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic. Biol. Med. 30 (2001) 1191-1212
28. Zhao C.Q., Young M.R., Diwan B.A., Coogan T.P., and Waalkes M.P. Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc. Natl. Acad. Sci. USA 94 (1997) 10907-10912
29. Achanzar W.E., Brambila E.M., Diwan B.A., Webber M.M., and Waalkes M.P. Inorganic arsenite-induced malignant transformation of human prostate epithelial cells. J. Natl. Cancer Inst. 94 (2002) 1888-1891
30. Chien C.W., Chiang M.C., Ho I.C., and Lee T.C. Association of chromosomal alterations with arsenite-induced tumorigenicity of human HaCaT keratinocytes in nude mice. Environ. Health Perspect. 112 (2004) 1704-1710
31. Sens D.A., Park S., Gurel V., Sens M.A., Garrett S.H., and Somji S. Inorganic cadmium- and arsenite-induced malignant transformation of human bladder urothelial cells. Toxicol. Sci. 79 (2004) 56-63
32. Wen G., Calaf G.M., Partridge M.A., Echiburu-Chau C., Zhao Y., Huang S., Chai Y., Li B., Hu B., and Hei T.K. Malignant (neoplastic) transformation of human small airway epithelial cells induced by arsenic. Mol. Med. 14 (2007) 2-10
33. Bachmeier B.E., Boukamp P., Lichtinghagen R., Fusenig N.E., and Fink E. Matrix metalloproteinases-2,-3,-7,-9 and -10, but not MMP-11, are differentially expressed in normal, benign tumorigenic and malignant human keratinocyte cell lines. Biol. Chem. 381 (2000) 497-507
34. Bernhard E.J., Gruber S.B., and Muschel R.J. Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc. Natl. Acad. Sci. USA 91 (1994) 4293-4297
35. Wang X., Tomso D.J., Chorley B.N., Cho H.Y., Cheung V.G., Kleeberger S.R., and Bell D.A. Identification of polymorphic antioxidant response elements in the human genome. Hum. Mol. Genet. 16 (2007) 1188-1200
36. Wong S.S., Tan K.C., and Goh C.L. Cutaneous manifestations of chronic arsenicism: review of seventeen cases. J. Am. Acad. Dermatol. 38 (1998) 179-185
37. Eckert R.L., Crish J.F., and Robinson N.A. The epidermal keratinocyte as a model for the study of gene regulation and cell differentiation. Physiol. Rev. 77 (1997) 397-424
38. Sumitomo S., Kumasa S., Iwai Y., and Mori M. Involucrin expression in epithelial tumors of oral and pharyngeal mucosa and skin. Oral Surg. Oral Med. Oral Pathol. 62 (1986) 155-163
39. Shen C.S., Tabata K., Matsuki M., Goto T., Yokochi T., and Yamanishi K. Premature apoptosis of keratinocytes and the dysregulation of keratinization in porokeratosis. Br. J. Dermatol. 147 (2002) 498-502
40. Said J.W., Sassoon A.F., Shintaku I.P., and Banks-Schlegel S. Involucrin in squamous and basal cell carcinomas of the skin: an immunohistochemical study. J. Invest. Dermatol. 82 (1984) 449-452
41. Sanchez-Carbayo M., Socci N.D., Charytonowicz E., Lu M., Prystowsky M., Childs G., and Cordon-Cardo C. Molecular profiling of bladder cancer using cDNA microarrays: defining histogenesis and biological phenotypes. Cancer Res. 62 (2002) 6973-6980
42. Zhang H., Yousem S.A., Franklin W.A., Elder E., Landreneau R., Ferson P., Keenan R., Whiteside T., and Levitt M.L. Differentiation and programmed cell death-related intermediate biomarkers for the development of non-small cell lung cancer: a pilot study. Hum. Pathol. 29 (1998) 965-971
43. Wakabayashi N., Itoh K., Wakabayashi J., Motohashi H., Noda S., Takahashi S., Imakado S., Kotsuji T., Otsuka F., Roop D.R., Harada T., Engel J.D., and Yamamoto M. Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation. Nat. Genet. 35 (2003) 238-245
44. Ahmed K., Gerber D.A., and Cochet C. Joining the cell survival squad: an emerging role for protein kinase CK2. Trends Cell Biol. 12 (2002) 226-230
45. Seldin D.C., and Leder P. Casein kinase II alpha transgene-induced murine lymphoma: relation to theileriosis in cattle. Science 267 (1995) 894-897
46. Munstermann U., Fritz G., Seitz G., Lu Y.P., Schneider H.R., and Issinger O.G. Casein kinase II is elevated in solid human tumours and rapidly proliferating non-neoplastic tissue. Eur. J. Biochem. 189 (1990) 251-257
47. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
48. Guzman E., Langowski J.L., and Owen-Schaub L. Mad dogs, Englishmen and apoptosis: the role of cell death in UV-induced skin cancer. Apoptosis 8 (2003) 315-325
49. Yamane K., and Kinsella T.J. CK2 inhibits apoptosis and changes its cellular localization following ionizing radiation. Cancer Res. 65 (2005) 4362-4367
50. Pi J., Zhang Q., Woods C.G., Wong V., Collins S., and Andersen M.E. Activation of Nrf2-mediated oxidative stress response in macrophages by hypochlorous acid. Toxicol. Appl. Pharmacol. 226 (2008) 236-243